Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Marsoni

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
JAMA Oncology|February 9, 2023
Cancer in Transgender and Gender-Diverse Persons: A ReviewAlberto Giovanni Leone, Dario Trapani, Matthew B Schabath, et al.
ESMO Open|February 2, 2018
Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical caseErika Martinelli, Teresa Troiani, Vincenzo Sforza, et al.
Cancers|January 11, 2022
Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver MetastasesValentina Giannini, Laura Pusceddu, Arianna Defeudis, et al.
JCO Precision Oncology|July 30, 2021
Empowering Clinical Decision Making in Oligometastatic Colorectal Cancer: The Potential Role of Drug Screening of Patient-Derived OrganoidsGianluca Mauri, Erika Durinikova, Alessio Amatu, et al.
ESMO Open|March 10, 2020
Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patientsGiovanni Crisafulli, Benedetta Mussolin, Andrea Cassingena, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment FeaturesEnrico Berrino, Maria Costanza Aquilano, Emanuele Valtorta, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2012
A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myelomaElisa Gallerani, Massimo Zucchetti, Dario Brunelli, et al.
Journal of Clinical Pathology|February 13, 2024
Clinicopathological characterisation of <i>MTAP</i> alterations in gastrointestinal cancersGianluca Mauri, Giorgio Patelli, Laura Roazzi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 29, 2012
An open-label phase 2 study of twice-weekly bortezomib and intermittent pegylated liposomal doxorubicin in patients with ovarian cancer failing platinum-containing regimensGabriella Parma, Rosanna Mancari, Gianluca Del Conte, et al.
Cancer Treatment Reviews|January 8, 2019
Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategiesGianluca Mauri, Elio Gregory Pizzutilo, Alessio Amatu, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
JAMA Oncology|February 9, 2023
Cancer in Transgender and Gender-Diverse Persons: A ReviewAlberto Giovanni Leone, Dario Trapani, Matthew B Schabath, et al.
ESMO Open|February 2, 2018
Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical caseErika Martinelli, Teresa Troiani, Vincenzo Sforza, et al.
Cancers|January 11, 2022
Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver MetastasesValentina Giannini, Laura Pusceddu, Arianna Defeudis, et al.
JCO Precision Oncology|July 30, 2021
Empowering Clinical Decision Making in Oligometastatic Colorectal Cancer: The Potential Role of Drug Screening of Patient-Derived OrganoidsGianluca Mauri, Erika Durinikova, Alessio Amatu, et al.
ESMO Open|March 10, 2020
Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patientsGiovanni Crisafulli, Benedetta Mussolin, Andrea Cassingena, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment FeaturesEnrico Berrino, Maria Costanza Aquilano, Emanuele Valtorta, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2012
A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myelomaElisa Gallerani, Massimo Zucchetti, Dario Brunelli, et al.
Journal of Clinical Pathology|February 13, 2024
Clinicopathological characterisation of <i>MTAP</i> alterations in gastrointestinal cancersGianluca Mauri, Giorgio Patelli, Laura Roazzi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 29, 2012
An open-label phase 2 study of twice-weekly bortezomib and intermittent pegylated liposomal doxorubicin in patients with ovarian cancer failing platinum-containing regimensGabriella Parma, Rosanna Mancari, Gianluca Del Conte, et al.
Cancer Treatment Reviews|January 8, 2019
Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategiesGianluca Mauri, Elio Gregory Pizzutilo, Alessio Amatu, et al.
Pageof 9